Key Takeaways

Trials show that doppler monitoring, compared with both continuous electronic fetal monitoring as well as intermittent fetal monitoring, has been associated with lower rates of cesarean birth and instrument-assisted vaginal births. Additionally, doppler monitoring is not associated with worse outcomes than both forms of electronic fetal monitoring.

These conclusions are based on trials that included both low- and higher-risk labors. Analysis of the high-risk subgroup did not show that continuous fetal monitoring improved outcomes and was consistent with overall results of the full Cochrane review.

For a low-risk healthy spontaneous labor, both ACOG & WHO recommend the use of doppler monitoring and do not recommend continuous fetal monitoring.

Current recommendations favoring continuous fetal monitoring for many higher-risk labors are based primarily on observational evidence, physiologic reasoning, pharmacological understandings, and expert consensus rather than randomized clinical trials demonstrating improved major birth outcomes.

Relevant Terminology

Cardiotocography (CTG)
Electronic monitoring that records the fetal heart rate and uterine contractions on a tracing used to assess fetal well-being during labor (NICE, 2022)

Continuous Electronic Fetal Monitoring
A method of continuously recording the baby's heart rate and the mother's uterine contractions using external or internal electronic sensors throughout labor (ACOG, 2019).

Intermittent Fetal Monitoring
Periodic assessment of the fetal heart rate at recommended intervals during labor rather than continuous monitoring. This may be performed using intermittent auscultation or intermittent electronic monitoring, depending on the clinical situation (ACOG, 2019).

Intermittent Auscultation (IA) (AKA Doppler Monitoring)
A method of fetal monitoring in which a healthcare provider listens to the baby's heart rate at regular intervals using a handheld Doppler device or fetoscope rather than continuously recording the heart rate (ACOG, 2019).

Pitocin (Synthetic Oxytocin)
A synthetic form of the hormone oxytocin that is administered intravenously to induce labor (start labor) or augment labor (strengthen labor after it has already begun) (ACOG, N.D.).

Consideration #1

The Evidence: The Cochrane Review

The Cochrane review (and meta-analysis) is considered to be the highest level of evidence on continuous electronic fetal monitoring. It includes 13 randomized trials and 37,000 women. Across the 13 trials, there was a mix of risk levels, with some trials including low and high risk, and others looking at specifically low- or high-risk labors. This review was funded by The Cochrane Pregnancy and Childbirth Group with no industry funding reported.

Findings:

Compared with intermittent auscultation, continuous intermittent fetal monitoring was associated with:

Outcome

Finding

Perinatal death

No significant reduction

Cerebral palsy

No significant reduction

Neonatal seizures

Approximately 50% lower relative risk

Cesarean birth

Increased

Instrument-assisted vaginal birth

Increased

An often-overlooked finding is that the lower rates of cesarean birth and instrument-assisted vaginal birth were associated with intermittent auscultation—not intermittent electronic monitoring (ALFIREVIC ET AL., 2017).

The reviewers also noted that while neonatal seizures were reduced, there was no clear evidence that this translated into improved long-term neurological outcomes, including cerebral palsy.

"Data for low-risk, high-risk, preterm pregnancy and high-quality trials subgroups were consistent with overall results." (ALFIREVIC ET AL., 2017)

Historical Context & Current Relevant Evidence

Newer research has found that not all newborn seizures are related to labor. Many are caused by conditions that begin before or after birth, meaning continuous fetal monitoring would not be expected to prevent them (CHAKKARAPANI ET AL., 2025).

When continuous electronic fetal monitoring was first introduced, cerebral palsy was widely believed to result from oxygen deprivation during labor. Researchers therefore expected that earlier detection of fetal distress would reduce the incidence. ³ We now know that most cases of cerebral palsy originate before labor, with only a small proportion resulting from acute intrapartum hypoxia. ⁵ This helps explain why the Cochrane review found that, despite reducing neonatal seizures, continuous electronic fetal monitoring does not reduce the incidence of cerebral palsy (ALFIREVIC ET AL., 2017;ACOG & AAP, 2014)

Consideration #2

Official Recommendations

ACOG Official Statements (Based on The Cochrane Review)

"A Cochrane review of 13 RCTs... found that continuous EFM was associated with an increase in cesarean deliveries and an increase in instrumental vaginal birth rate. However... the authors found no significant difference in the rates of perinatal death or cerebral palsy when compared with intermittent auscultation." - ACOG (ACOG, 2019)

The Cochrane authors concluded that continuous electronic fetal monitoring and intermittent fetal monitoring increased the rates of cesarean birth and instrument-assisted vaginal birth but did not reduce the risk of perinatal death or cerebral palsy. Although continuous monitoring was associated with an approximately 50% lower relative risk of neonatal seizures, there is no evidence that this reduction translated into improved long-term neurological outcomes (ALFIREVIC ET AL., 2017).

“For a woman who is at term in spontaneous labor with a fetus in vertex presentation, labor management may be individualized (depending on maternal and fetal condition and risks) to include techniques such as intermittent auscultation and nonpharmacologic methods of pain relief.” - (ACOG, 2019)

“Obstetrician–gynecologists and other obstetric care providers and facilities should consider adopting protocols and training staff to use a hand-held Doppler device” - ACOG (ACOG, 2019)

WHO (World Health Organization)

“Intermittent auscultation of the fetal heart rate with either a Doppler ultrasound device or Pinard fetal stethoscope is recommended for healthy pregnant women in labour.”

Consideration #3:

Appropriate Uses

Appropriate Uses for Intermittent Auscultation (Doppler)

Intermittent auscultation (doppler) is generally appropriate for women entering labor with a healthy, term, low-risk pregnancy, when labor begins spontaneously, and no maternal, fetal, or labor complications are present. ACOG states that either intermittent auscultation or electronic monitoring may be used when no complications or risk factors exist (ACOG, 2025A), while NICE and WHO specifically recommend intermittent auscultation for healthy, low-risk women in labor (NICE, 2026; WHO, 2018)

Risk Factors That May Warrant Continuous Electronic Fetal Monitoring

  • An abnormal fetal heart rate detected by intermittent auscultation

  • Induction or augmentation with Pitocin

  • Previous cesarean birth

  • Significant maternal illness, such as preeclampsia or diabetes requiring medication

  • Fetal growth restriction, prematurity, or other known fetal concerns

  • Meconium accompanied by additional risk factors or fetal heart-rate abnormalities.

  • Vaginal bleeding, maternal fever, excessive contractions, or other complications arising during labor

(NICE, 2026; ACOG, 2025B)

Consideration #4

🌍A Global Perspective to Fetal Monitoring

Country

Low-risk fetal monitoring recommendation

Use of continuous EFM/CTG

Norway

Intermittent auscultation is recommended. (Moderate quality data)

Routine admission CTG and continuous CTG are not recommended without a clinical indication. (High quality data)

Japan

After a reassuring 20-minute CTG, fetal heart rate may be monitored by intermittent auscultation every 15–90 minutes, with another CTG within six hours. (Moderate quality data)

Continuous CTG throughout latent labor is permitted but not required. (Moderate quality data)

Sweden

First stage: intermittent auscultation or intermittent CTG. Second stage: auscultation or continuous CTG. (Moderate quality data)

Admission CTG is recommended for all women; continuous CTG is not required throughout low-risk labor. (Moderate quality data)

(BLIX ET AL., 2019; JSOG & JAOG, 2011; JSOG & JAOG, 2023; NORWEGIAN MIDWIVES ASSOCIATION, 2025)

These countries were selected for their strong maternal and neonatal outcomes and the availability of clear, moderate- to high-quality fetal-monitoring guidance (OECD, 2025; UN IGME, 2025; WHO ET AL., 2025).

Author Identified Remaining Research Needs

New research is needed on the following comparisons/topics:

  • Comparison of monitoring methods between healthy low-risk spontaneous labors and low-risk women receiving Pitocin for induction or augmentation (speeding up of labor with Pitocin).

  • New comparison trials with contemporary technology.

  • Comparison with continuous fetal monitoring vs intermittent auscultation looking at birth experiences.

  • Determining the safest and most effective frequency of intermittent auscultation during the first and second stages of labor.

Disclaimer

This article is provided for general educational and informational purposes only and does not constitute individualized medical advice, diagnosis, or treatment. Research findings and professional guidelines may not apply to every person or clinical circumstance. Discuss decisions about your care with a qualified healthcare professional who understands your individual history and needs. Although The Birth Review makes reasonable efforts to represent sources accurately, information may become outdated, studies may contain limitations, and qualified experts may interpret the same evidence differently.

References

(ACOG & AAP, 2014) American College of Obstetricians and Gynecologists, & American Academy of Pediatrics. (2014). Neonatal encephalopathy and neurologic outcome (2nd ed.). American College of Obstetricians and Gynecologists. https://www.acog.org/clinical/clinical-guidance/task-force-report/articles/2014/neonatal-encephalopathy-and-neurologic-outcome

(ACOG, 2019) American College of Obstetricians and Gynecologists. (2019, February). Approaches to limit intervention during labor and birth (Committee Opinion No. 766). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/02/approaches-to-limit-intervention-during-labor-and-birth

(ACOG, 2025A) American College of Obstetricians and Gynecologists. (2025). Fetal heart rate monitoring during labor. https://www.acog.org/womens-health/faqs/fetal-heart-rate-monitoring-during-labor

(ACOG, 2025B) American College of Obstetricians and Gynecologists. (2025, October). Intrapartum fetal heart rate monitoring: Interpretation and management (Clinical Practice Guideline No. 10). https://www.acog.org/clinical/clinical-guidance/clinical-practice-guideline/articles/2025/10/intrapartum-fetal-heart-rate-monitoring-interpretation-and-management

(ACOG, N.D.) American College of Obstetricians and Gynecologists. (n.d.). revitalize: Obstetrics data definitions. https://www.acog.org/practice-management/health-it-and-clinical-informatics/revitalize-obstetrics-data-definitions

(ALFIREVIC ET AL., 2017) Alfirevic, Z., Gyte, G. M. L., Cuthbert, A., & Devane, D. (2017). Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database of Systematic Reviews, 2017(2), Article CD006066. https://doi.org/10.1002/14651858.CD006066.pub3

(CHAKKARAPANI ET AL., 2025) Chakkarapani, E., de Vries, L. S., Ferriero, D. M., & Gunn, A. J. (2025). Neonatal encephalopathy and hypoxic-ischemic encephalopathy: The state of the art. Pediatric Research, 98(7), 2444–2458. https://doi.org/10.1038/s41390-025-03986-2

(NICE, 2022) National Institute for Health and Care Excellence. (2022, December). Fetal monitoring in labour (NICE Guideline No. NG229). https://www.nice.org.uk/guidance/ng229

(NICE, 2026) National Institute for Health and Care Excellence. (2026, March 25). Fetal monitoring in labour: Recommendations (NICE Guideline NG229). https://www.nice.org.uk/guidance/ng229/chapter/Recommendations

(OECD, 2025) Organisation for Economic Co-operation and Development. (2025). Maternal and infant mortality. In Health at a Glance 2025: OECD indicators. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/maternal-and-infant-mortality_4379b33b.html

(UN IGME, 2025) United Nations Inter-agency Group for Child Mortality Estimation. (2025). Levels and trends in child mortality 2025. UNICEF. https://data.unicef.org/resources/levels-and-trends-in-child-mortality-2025/

(WHO, 2018) World Health Organization. (2018). WHO recommendations: Intrapartum care for a positive childbirth experience. https://www.who.int/publications/i/item/9789241550215

(WHO ET AL., 2025) World Health Organization, UNICEF, UNFPA, World Bank Group, & United Nations Population Division. (2025, April). Trends in maternal mortality 2000 to 2023. https://www.who.int/publications/i/item/9789240108462